HopeStage
Back to all studies
CompletedNCT03701100

The Effects of Bimodal tDCS on Illness Severity, Insight, Functional Outcomes, Neurocognition and HRV in Schizophrenia

Device studyAges 20–65Taiwan
The study in practice

Understand this study

Who was this study for?

This study was for people with schizophrenia. Listed age limits: 20 years to 65 years. Other eligibility criteria applied.

Listed locations
TaipeiSee all locations and recruitment
Study clarity

Study information

Study start dateStarted: July 17, 2017
Recruitment status
Completed
Enrollment listed in the registry
60
Sponsor
Tri-Service General Hospital (TSGH)
Sponsor type
Hospital / academic medical center
Study type
Device
Intervention type
DEVICE
Study phase
Not clearly listed
Locations
Taiwan
Age range
From 20 Years to 65 Years
Official registry ID
NCT03701100
Official title
Show the full official title

The Effects of Bimodal Anodal Transcranial Direct Current Stimulation Over Bilateral Prefrontal Cortex on Illness Severity, Insight, Functional Outcomes, Quality of Life, Neurocognition and Heart Rate Variability (HRV) in Schizophrenia

Looking for a study you can join?

Explore recruiting studies

Get this study by email

HopeStage may email me about this study.
Loading the security check...

Recruitment & locations

Completed

Taipei

FAQ

Questions about this study

Who is behind this study?

The study sponsor is Tri-Service General Hospital (TSGH), a hospital or academic medical center.

Who was this study for?

This study was for people with schizophrenia. Listed age limits: 20 years to 65 years. Other eligibility criteria applied.

Want to explore more studies?

Explore studies